Complications of long and intermediate term venous catheters in cystic fibrosis patients: A multicenter study

Journal of Cystic Fibrosis

Volumn 17, Issue 1, 2018, Pages 96-104

  May, Teresa L ^a   Gifford, Alex H ^b   Lahiri, Thomas ^c   Black, Adam ^a   Trang, Janet ^c   Cornell, Alexandra G ^d   Gonzalez, Karyll ^a   Morin, Scott ^e   Napier, Mark ^f   Duarte, Christine W ^a   Zuckerman, Jonathan B ^a  

^a MAINE MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Southern Maine Medical Center   (United States)

^f Anthem Incorporated   (United States)

Author keywords

Central line; CFF Patient Registry; Infectious complications; Pulmonary exacerbation

Indexed keywords

ADULT; ANTICOAGULATION; ARTICLE; BODY MASS; BURKHOLDERIA CEPACIA; CATHETER INFECTION; CHILD; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; RESPIRATORY SYSTEM; RETROSPECTIVE STUDY; RISK FACTOR; ADOLESCENT; ADVERSE DEVICE EFFECT; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLASSIFICATION; CLINICAL PRACTICE; INFECTION; MICROBIOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; REGISTER; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; THROMBOSIS; UNITED STATES;

ADOLESCENT; ADULT; CATHETERIZATION, PERIPHERAL; CENTRAL VENOUS CATHETERS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PRACTICE PATTERNS, PHYSICIANS'; PROSTHESIS-RELATED INFECTIONS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; UNITED STATES;

EID: 85020132571     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.04.014     Document Type: Article

References (29)

1. Morin, S.A., Gifford, A., Parker, H., Wittaker, L., Lahiri, T., Cornell, A., et al. Complications of intermediate and long-term central venous catheters in CF patients. Pediatr. Pulmonol., 30, 2007, A576.
2. May, T.L., Gonzalez, K., Trang, J., Cornell, A., Sender, L., Duarte, C., et al. Complications of long adn intermediate term venous catheters in CF patients. Chest, 144, 2013, 755A.
3. May, T.B.A., Gonzalex, K., Trang, J., Lahiri, T., Duarte, C., Sender, L., et al. Regional variation in complication rates of central venous catheters in CF patients. Pediatr. Pulmonol., 45, 2016, A566.
4. Cystic Fibrosis Foundation Patient Registry, Annual data report. Bethesda, Maryland 2015. 2015.
5. Flume, P.A., Mogayzel, P.J. Jr., Robinson, K.A., et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am. J. Respir. Crit. Care Med. 180:9 (2009), 802–808.
6. Cassey, J., Ford, W.D., O'Brien, L., Martin, A.J., Totally implantable system for venous access in children with cystic fibrosis. Clin. Pediatr. 27:2 (1988), 91–95.
7. Ball, A.B., Duncan, F.R., Foster, F.J., Davidson, T.I., Watkins, R.M., Hodson, M.E., Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir. Med. 83:5 (1989), 429–431.
8. Burdon, J., Conway, S.P., Murchan, P., Lansdown, M., Kester, R.C., Five years’ experience of PAS Port intravenous access system in adult cystic fibrosis. Eur. Respir. J. 12:1 (1998), 212–216.
9. Aitken, M.L., Tonelli, M.R., Complications of indwelling catheters in cystic fibrosis: a 10-year review. Chest 118:6 (2000), 1598–1602.
10. Rodgers, H.C., Liddle, K., Nixon, S.J., Innes, J.A., Greening, A.P., Totally implantable venous access devices in cystic fibrosis: complications and patients’ opinions. Eur. Respir. J. 12:1 (1998), 217–220.
11. Deerojanawong, J., Sawyer, S.M., Fink, A.M., Stokes, K.B., Robertson, C.F., Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax 53:4 (1998), 285–289.
12. Dupont, C., Gouya, H., Panzo, R., et al. Complications of peripherally inserted central catheters in adults with cystic fibrosis or bronchiectasis. J. Vasc. Access 16:3 (2015), 245–249.
13. Mermis, J.D., Strom, J.C., Greenwood, J.P., et al. Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. Ann Am Thorac Soc 11:9 (2014), 1404–1410.
14. Munck, A., Malbezin, S., Bloch, J., et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur. Respir. J. 23:3 (2004), 430–434.
15. Borowitz, D., Baker, R.D., Stallings, V., Consensus report on nutrition for pediatric patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 35:3 (2002), 246–259.
16. Dal Molin, A., Di Massimo, D.S., Braggion, C., et al. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. J. Vasc. Access 13:3 (2012), 290–295.
17. Royle, T.J., Davies, R.E., Gannon, M.X., Totally implantable venous access devices - 20 years’ experience of implantation in cystic fibrosis patients. Ann. R. Coll. Surg. Engl. 90:8 (2008), 679–684.
18. Evans, R.S., Sharp, J.H., Linford, L.H., et al. Reduction of peripherally inserted central catheter-associated DVT. Chest 143:3 (2013), 627–633.
19. Nifong, T.P., McDevitt, T.J., The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest 140:1 (2011), 48–53.
20. Bui, S., Babre, F., Hauchecorne, S., et al. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis. J. Cyst. Fibros. 8:5 (2009), 326–331.
21. Petrauskiene, V., Falk, M., Waernbaum, I., Norberg, M., Eriksson, J.W., The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 48:5 (2005), 1017–1021.
22. Carr, M.E., Diabetes mellitus: a hypercoagulable state. J. Diabetes Complicat. 15:1 (2001), 44–54.
23. Heit, J.A., Leibson, C.L., Ashrani, A.A., Petterson, T.M., Bailey, K.R., Melton, L.J. 3rd., Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler. Thromb. Vasc. Biol. 29:9 (2009), 1399–1405.
24. Takemoto, C.M., Venous thromboembolism in cystic fibrosis. Pediatr. Pulmonol. 47:2 (2012), 105–112.
25. Williams, V., Griffiths, A.B., Yap, Z.L., et al. Increased thrombophilic tendency in pediatric cystic fibrosis patients. Clin. Appl. Thromb. Hemost. 16:1 (2010), 71–76.
26. Balfour-Lynn, I.M., Malbon, K., Burman, J.F., Davidson, S.J., Thrombophilia in children with cystic fibrosis. Pediatr. Pulmonol. 39:4 (2005), 306–310.
27. Barker, M., Thoenes, D., Dohmen, H., Friedrichs, F., Pfannenstiel, C., Heimann, G., Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis. Pediatr. Pulmonol. 39:2 (2005), 156–161.
28. Raffini, L.J., Raybagkar, D., Blumenstein, M.S., Rubenstein, R.C., Manno, C.S., Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J. Pediatr. 148:5 (2006), 659–664.
29. Nash, E.F., Helm, E.J., Stephenson, A., Tullis, E., Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. J. Vasc. Interv. Radiol. 20:3 (2009), 347–351.